Skip to main content
. 2021 Jun 18;9(6):e002771. doi: 10.1136/jitc-2021-002771

Figure 2.

Figure 2

Cumulative incidence of pericardial disease in patients treated with ICI (n=2842) versus those not treated with ICI (n=2699), Gray’s test p<0.001. ICIs, immune checkpoint inhibitors.